Acute toxicity and "structure-action" dependence of 4-(R-benzylidenamino)-5-methyl-4H-1,2,4-triazoles 3-tion
DOI:
https://doi.org/10.14739/2409-2932.2017.2.103757Keywords:
toxicity tests, preclinical drug evaluation, 1, 2, 4-triazole, biological activityAbstract
The achievements of modern pharmaceutical chemistry allow to develop a wide range of potential new drugs. However, their success in clinical practice depends on their safety. Therefore, the presence of evidence of their safety and efficacy is an integral part of any research.
The aim of our study was to investigate acute toxicity of synthesized 1,2,4-triazoles derivatives, studying behavioral reactions to toxic doses and dependence "structure – action".
Methods. To install middle lethal dose (LD50) the substance was administered intraperitoneally as an aqueous suspension stabilized by Tween-80. The substance was administrated once to four groups of laboratory animals (white nonlinear rats), 2 animals in each group. Multiple doses were administered, including the dose which does not cause the death of any animal and the dose which causes the death of all animals in the group. After administration of the compounds we conducted surveillance for two weeks to all animals who stayed alive.
Results. The least toxic compound among the studied 4-(R-benzylidenamino)-5-methyl-4H-1,2,4-triazoles-3-thiones was compound 1 with an index of 840 mg/kg, which contains 4-methoxybenzilidene substituent on N4-nitrogen atom and the most toxic was compound 5, which has 4-brombenzilidene substituent at the same prosition (LD50 – 284 mg/kg). So we see that replacing bromine atom leads to the reduction of toxic properties. So we can assume that the introduction of a halogen atom to benzilidene phenolic core substituent increases the toxic properties of the synthesized compounds.
An interesting pattern is observed for compounds 2–4, which contain two methoxy substituents, and their LD50 almost did not changed and range from 764 to 790 mg/kg.
Conclusions. The study has found that 4-(R-benzylidenamino)-5-methyl-4H-1,2,4-triazol-3-tiones belonging to IV Class of toxicity. In addition, these compounds can be subjected to further biological study.
References
Shcherbak, M. O., Kaplaushenko, A. G., & Belenichev, I. F. (2014) Hostra toksychnist 4-amino-5-(2-, 3-, 4-nitrofenil)-1,2,4-triazol-3-tioniv ta yikh pokhidnykh [Acute toxicityof 4-amino-5-(2-, 3-, 4-nitrophenyl)-1,2,4-triazole-3-thiones and its derivatives ]. Current issues in pharmacy and medicine: science and practice, 3(16), 63–66. [in Ukrainian]. doi: http://dx.doi.org/10.14739/2409-2932.2014.3.33865.
Odyntsova, V. M., Panasenko, O. I., & Knysh, Ye. G. (2015) Hostra toksychnist 2-(5-(adamantan-1-il)-4R-1,2,4-triazol-3-iltio) otstovykh kyslot ta yikhnikh pokhidnykh solei [Acute toxicity of 2-(5-(adamantane-1-yl)-4R-1,2,4-triazole-3-ylthio) of the acetic acids and their salts’ derivatives]. Current issues in pharmacy and medicine: science and practice, 3 (19), 64-66. [in Ukrainian]. doi:http://dx.doi.org/10.14739/2409-2932.2015.3.52271.
Panasenko, O. I. (2005) Syntez, peretvorennia, fizyko-khimichni ta biolohichni vlastyvosti pokhidnykh 1,2,4-triazolu (Dis… dokt. farm. nauk). [Synthesis, transformation, physical, chemical and biological properties of derivatives of 1,2,4-triazoles. Dr. farm. sci. diss.]. Kyiv. [in Ukrainian].
Samelyuk, Yu. G., & Kaplaushenko A.G. (2015) Hostra toksychnist 5-(2-, 3-, 4-metoksyfenil, (3,4,5-trymetoksyfenil)-)-1,2,4-triazol-3-tioniv ta yikh tiopokhidnykh [Acute toxicity of 5-(2-, 3-, 4-methoxyphenyl, (3,4,5-trimethoxyphenyl)-)-1,2,4-triazole-3-thiones and its thioderivatives]. Current issues in pharmacy and medicine: science and practice, 3(19), 57–60. [in Ukrainian]. doi: http://dx.doi.org/10.14739/2409-2932.2015.3.52660.
Prozorovskii, V. B. (2007) Statisticheskaya obrabotka rezulʹtatov farmakologicheskikh issledovanij [Statistic processing of data of pharmacological investigations]. Psikhofarmacologiya i biologicheskaya narkologiya, 7(3–4), 2090–2120. [in Russian].
Hotsulia, A. S., Panasenko, O. I., Knysh, Ye. H., & Pruhlo, Ye. S. (2010) Syntez, fizyko-khimichni vlastyvosti ta hostra toksychnist 2-[5-R-4-(2-metoksyfenil)-1,2,4-triazol-3-iltio]-1-aryletanoliv [Synthesis, physico-chemical properties and acute toxicity 2- [5-R-4- (2-methoxyphenyl) -1,2,4-triazoles 3-iltio] -1-aryletanoliv]. Farmatsevtychnyi zhurnal, 6, 32–35. [in Ukrainian].
Odyntsova, V. M., Panasenko, O. I., & Knysh, Ye. H. (2015) Hostra toksychnist S-alkilpokhidnykh 5-(adamantan-1-il)-4R-1,2,4- triazol-3-tionu [Acute toxicity of s-alkylderivatives of 5-(adamantane-1-yl)-4r-1,2,4-triazole-3-thione]. Farmatsevtychnyi chasopys, 2, 6–8. [in Ukrainian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
